Cargando…

Implementation of Double Immune Checkpoint Blockade Increases Response Rate to Induction Chemotherapy in Head and Neck Cancer

SIMPLE SUMMARY: The study compares the effects on complete remission rate (CR) of a single dose of durvalumab/tremelimumab immediately after a single-cycle platinum and docetaxel as part of induction therapy for a controlled trial in head and neck cancer with chemotherapy alone from a historical col...

Descripción completa

Detalles Bibliográficos
Autores principales:	Semrau, Sabine, Gostian, Antoniu-Oreste, Traxdorf, Maximilian, Eckstein, Markus, Rutzner, Sandra, von der Grün, Jens, Illmer, Thomas, Hautmann, Matthias, Klautke, Gunther, Laban, Simon, Brunner, Thomas, Tamaskovics, Bálint, Frey, Benjamin, Zhou, Jian-Guo, Geppert, Carol-Immanuel, Hartmann, Arndt, Balermpas, Panagiotis, Budach, Wilfried, Gaipl, Udo, Iro, Heinrich, Fietkau, Rainer, Hecht, Markus
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8073509/ https://www.ncbi.nlm.nih.gov/pubmed/33921668 http://dx.doi.org/10.3390/cancers13081959

Ejemplares similares

Safety and efficacy of single cycle induction treatment with cisplatin/docetaxel/ durvalumab/tremelimumab in locally advanced HNSCC: first results of CheckRad-CD8
por: Hecht, Markus, et al.
Publicado: (2020)

Induction chemoimmunotherapy followed by CD8+ immune cell-based patient selection for chemotherapy-free radioimmunotherapy in locally advanced head and neck cancer
por: Hecht, Markus, et al.
Publicado: (2022)

F18-FDG PET/CT imaging early predicts pathologic complete response to induction chemoimmunotherapy of locally advanced head and neck cancer: preliminary single-center analysis of the checkrad-cd8 trial
por: Beck, M., et al.
Publicado: (2022)

Questionnaire-based detection of immune-related adverse events in cancer patients treated with PD-1/PD-L1 immune checkpoint inhibitors
por: Griewing, Luisa Maria, et al.
Publicado: (2021)

Predictive Value of Multiparametric MRI for Response to Single-Cycle Induction Chemo-Immunotherapy in Locally Advanced Head and Neck Squamous Cell Carcinoma
por: Hellwig, Konstantin, et al.
Publicado: (2021)

Prospective Evaluation of All-lesion Versus Single-lesion Radiotherapy in Combination With PD-1/PD-L1 Immune Checkpoint Inhibitors
por: Schubert, Philipp, et al.
Publicado: (2020)

Reduction of Elective Radiotherapy Treatment Volume in Definitive Treatment of Locally Advanced Head and Neck Cancer—Comparison of a Prospective Trial with a Revised Simulated Contouring Approach
por: Weissmann, Thomas, et al.
Publicado: (2021)

Relevance of the time interval between surgery and adjuvant radio (chemo) therapy in HPV-negative and advanced head and neck carcinoma of unknown primary (CUP)
por: Balk, Matthias, et al.
Publicado: (2021)

Explainable convolutional neural networks for assessing head and neck cancer histopathology
por: Dörrich, Marion, et al.
Publicado: (2023)

Differences and Similarities in the Pattern of Early Metabolic and Morphologic Response after Induction Chemo-Immunotherapy versus Induction Chemotherapy Alone in Locally Advanced Squamous Cell Head and Neck Cancer
por: Beck, Michael, et al.
Publicado: (2022)

Hypofractionated Radiotherapy Upregulates Several Immune Checkpoint Molecules in Head and Neck Squamous Cell Carcinoma Cells Independently of the HPV Status While ICOS-L Is Upregulated Only on HPV-Positive Cells
por: Wimmer, Sebastian, et al.
Publicado: (2021)

Factors Influencing the Outcome of Head and Neck Cancer of Unknown Primary (HNCUP)
por: Balk, Matthias, et al.
Publicado: (2022)

Salvage laryngectomy after primary radio- and radiochemotherapy: A retrospective study
por: Sievert, Matti, et al.
Publicado: (2021)

Salvage-Laryngektomie nach primärer Radio- und Radiochemotherapie: Eine retrospektive Fallzusammenfassung
por: Sievert, Matti, et al.
Publicado: (2021)

Deep learning for automatic head and neck lymph node level delineation provides expert-level accuracy
por: Weissmann, Thomas, et al.
Publicado: (2023)

Radiotherapy combined with docetaxel alters the immune phenotype of HNSCC cells and results in increased surface expression of CD137 and release of HMGB1 of specifically HPV-positive tumor cells
por: Grottker, Fridolin, et al.
Publicado: (2023)

Advance directives in patients with head and neck cancer - status quo and factors influencing their creation
por: Allner, Moritz, et al.
Publicado: (2022)

A comparison between p16-positive head and neck cancer of unknown primary (HPV-HNCUP) and oropharyngeal squamous cell carcinoma (HPV-OPSCC): are they the same disease?
por: Balk, Matthias, et al.
Publicado: (2023)

Considerations for Continuing Semielective and Emergency Otolaryngological Procedures During the COVID-19 Pandemic
por: Mueller, Sarina K., et al.
Publicado: (2021)

High-grade salivary gland cancer: is surgery followed by radiotherapy an adequate treatment to reach tumor control? Results from a tertiary referral centre focussing on incidence and management of distant metastases
por: Freitag, Viola, et al.
Publicado: (2021)

Definitive Radiochemotherapie von lokal fortgeschrittenen Kopf-Hals-Tumoren in Kombination mit Immuncheckpointinhibition – neue Konzepte gefragt
por: Hecht, Markus, et al.
Publicado: (2021)

Prospective development and validation of a liquid immune profile-based signature (LIPS) to predict response of patients with recurrent/metastatic cancer to immune checkpoint inhibitors
por: Zhou, Jian-Guo, et al.
Publicado: (2021)

Deterioration of Health-Related Quality of Life Scores under Treatment Predicts Longer Survival
por: Jörling, Maike, et al.
Publicado: (2020)

Differences in and Prognostic Value of Quality of Life Data in Rectal Cancer Patients with and without Distant Metastases
por: Frank, Fabian, et al.
Publicado: (2020)

Baseline Quality of Life of Physical Function Is Highly Relevant for Overall Survival in Advanced Rectal Cancer
por: Fitz, Tim, et al.
Publicado: (2022)

Patterns of care analysis for salivary gland cancer: a survey within the German Society of Radiation Oncology (DEGRO) and recommendations for daily practice
por: von der Grün, Jens, et al.
Publicado: (2021)

Case report: Patient specific combination of surgery and immunotherapy in advanced squamous cell carcinoma of the head and neck – a case series and review of literature
por: Olmos, Manuel, et al.
Publicado: (2022)

Validity of tissue homogeneity in confocal laser endomicroscopy on the diagnosis of laryngeal and hypopharyngeal squamous cell carcinoma
por: Sievert, Matti, et al.
Publicado: (2022)

Immune biological rationales for the design of combined radio- and immunotherapies
por: Hader, Michael, et al.
Publicado: (2020)

Analgesia after tonsillectomy with controlled intravenous morphine — overdue or exaggerated?
por: Gostian, Magdalena, et al.
Publicado: (2021)

Postoperative management of antithrombotic medication in microvascular head and neck reconstruction: a comparative analysis of unfractionated and low-molecular-weight heparin
por: Sievert, Matti, et al.
Publicado: (2020)

Salivary gland carcinoma (SGC) with perineural spread and/or positive resection margin – high locoregional control rates after photon (chemo) radiotherapy - experience from a monocentric analysis
por: Haderlein, Marlen, et al.
Publicado: (2019)

Cartilaginous bending spring tympanoplasty: a temporal bone study and first clinical results
por: Rupp, Robin, et al.
Publicado: (2022)

The Offprint of an Abnormal Pre-Parotidectomy Electrodiagnostic Finding in a Normally Functioning Facial Nerve: Correlation with Intraoperative Findings, Histology and Postoperative Facial Nerve Function †
por: Katheder, Verena, et al.
Publicado: (2022)

12 × 6 Gy stereotactic radiotherapy for lung tumors. Is there a difference in response between lung metastases and primary bronchial carcinoma?
por: Lubgan, Dorota, et al.
Publicado: (2021)

Chemoradiation Increases PD-L1 Expression in Certain Melanoma and Glioblastoma Cells
por: Derer, Anja, et al.
Publicado: (2016)

Risk of magnetic resonance imaging-induced magnet dislocation for different types of cochlear implants: a single-center retrospective study
por: Rupp, Robin, et al.
Publicado: (2023)

Treatment response lowers tumor symptom burden in recurrent and/or metastatic head and neck cancer
por: Hecht, Markus, et al.
Publicado: (2020)

A Prospective Real-World Multi-Center Study to Evaluate Progression-Free and Overall Survival of Radiotherapy with Cetuximab and Platinum-Based Chemotherapy with Cetuximab in Locally Recurrent Head and Neck Cancer
por: Hecht, Markus, et al.
Publicado: (2021)

Reply: Adjuvant chemoradiotherapy is no alternative to intensified neoadjuvant chemoradiotherapy for local and systemic control in patients with locally advanced rectal cancer
por: Klautke, G, et al.
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_6tq93fedfb5j87mhbbjaemvpcg